— COMPANY

“Safe, Simple & Affordable Cell Therapy”

TCUBEit Inc. is a biotech startup company focusing on T cell-based immuno-therapy.
T cells in the human body examine cancers or infections and rid them from the body.
We are dedicated to curating both the quantity & quality of T cells from patients.

Sun Taek Kim PhD CEO

• KAIST (1990-1994) Bachelor of Science in biology
• KAIST (1994-1996) Master of biochemistry
• KAIST (1996-2000) Doctor of Immunology
• Biomolecular Engineering Research Institute, Japan (1997-1998), Research Fellow
• Genofocus Inc. Daejeon, Republic of Korea (2000-2002), Research Scientist
• Aprogen Inc. Daejeon, Republic of Korea (2002-2003), Senior Scientist
• Harvard Medical School/Dana-Farber Cancer Institute (2003-2012), Instructor
• Medytox Inc. Suwon, Republic of Korea (2012-2018), Principal Scientist
• M5 Bioscience Group, Seoul, Republic of Korea (2019), CTO
• TCUBEit Inc. Sejong, Republic of Korea (2019-Present), Founder/ CEO

Research Team Members

GiHyuck Ryu

Chief Technology Officer
⌈  T cell therapy/New drug  ⌋

• Medytox / Principal Scientist• Enzynomics / R&D Director• KAIST/PhD in Molecular Biology

Yoon Joong Kang

Chief Scientific Officer
⌈  Immune-Profiling  ⌋

• Joongwon U / Professor• Harvard Medical School / Post Doc.• KNU /PhD inGenetic Engineering

Sangnam Nam

Chief Information Officer
⌈Deep Learning/Image Analysis⌋

• Amazon / Senior Software Engineer• Samsung Elec / Principal Engineer• Inria (France)/ Post Doc.• U.of Wisconsin-Madison / PhD in Mathematics

  • Name of Company : TCUBEit Inc.

  • Establishment : October 18, 2019

  • Employees : 17 people (5 PhD, 5 Masters, 5 B.S…)

  • Address

  • HQ : Sejong SB Plaza | #904, Sejong

  • R&D/Production : C&V Center | Osong, Cheongju | Republic of Korea

Main Business

  •  Next-gen T cell Manufacturing Platform  | T-CAMP, T-GUNS

  • Pipelines for HCC and gastric cancer

  • Human Immunity Profiling